Feng‐Chun Yang

8.9k total citations · 1 hit paper
131 papers, 5.6k citations indexed

About

Feng‐Chun Yang is a scholar working on Molecular Biology, Hematology and Neurology. According to data from OpenAlex, Feng‐Chun Yang has authored 131 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 46 papers in Hematology and 27 papers in Neurology. Recurrent topics in Feng‐Chun Yang's work include Acute Myeloid Leukemia Research (32 papers), Neurofibromatosis and Schwannoma Cases (27 papers) and Hematopoietic Stem Cell Transplantation (15 papers). Feng‐Chun Yang is often cited by papers focused on Acute Myeloid Leukemia Research (32 papers), Neurofibromatosis and Schwannoma Cases (27 papers) and Hematopoietic Stem Cell Transplantation (15 papers). Feng‐Chun Yang collaborates with scholars based in United States, China and Japan. Feng‐Chun Yang's co-authors include Mingjiang Xu, D. Wade Clapp, Karl Staser, David A. Williams, Jin Yuan, David A. Ingram, Chen‐Leng Cai, Jiapeng Wang, Zhe Li and Bruce Petersen and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Feng‐Chun Yang

129 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies

2011 507 citations Feng‐Chun Yang, Mingjiang Xu et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Feng‐Chun Yang United States	39	2.8k	1.2k	1.1k	1.1k	764	131	5.6k
Toshihide Iwashita Japan	36	3.5k 1.3×	1.7k 1.4×	1.2k 1.1×	251 0.2×	859 1.1×	106	7.3k
Marco Seri Italy	38	2.3k 0.8×	645 0.5×	488 0.4×	315 0.3×	318 0.4×	193	5.3k
Neil V. Morgan United Kingdom	42	3.0k 1.1×	807 0.7×	754 0.7×	192 0.2×	671 0.9×	109	5.7k
Carrie J. Shawber United States	33	3.3k 1.2×	351 0.3×	617 0.6×	373 0.4×	309 0.4×	74	5.3k
D. Wade Clapp United States	29	1.2k 0.4×	961 0.8×	856 0.8×	400 0.4×	380 0.5×	64	3.1k
Carol A. Wise United States	35	2.7k 1.0×	571 0.5×	1.6k 1.4×	358 0.3×	268 0.4×	85	5.7k
Akiko Shimamura United States	40	4.0k 1.4×	1.5k 1.2×	1.2k 1.1×	130 0.1×	625 0.8×	128	6.6k
Arupa Ganguly United States	48	2.5k 0.9×	278 0.2×	581 0.5×	356 0.3×	410 0.5×	144	6.5k
John M. Cunningham United States	36	3.0k 1.1×	780 0.6×	531 0.5×	151 0.1×	640 0.8×	137	5.1k
Jan P. Dumanski Sweden	43	3.6k 1.3×	336 0.3×	372 0.3×	1.4k 1.3×	690 0.9×	146	7.4k

Countries citing papers authored by Feng‐Chun Yang

Since Specialization

Citations

This map shows the geographic impact of Feng‐Chun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Chun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Chun Yang more than expected).

Fields of papers citing papers by Feng‐Chun Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng‐Chun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Chun Yang. The network helps show where Feng‐Chun Yang may publish in the future.

Co-authorship network of co-authors of Feng‐Chun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Feng‐Chun Yang. A scholar is included among the top collaborators of Feng‐Chun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng‐Chun Yang. Feng‐Chun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Ganqian, Qian Lai, Huacheng Luo, et al.. (2025). HoxBlinc lncRNA reprograms CTCF-independent TADs to drive leukemic transcription and HSC dysregulation in NUP98-rearranged leukemia. Journal of Clinical Investigation. 135(7). 2 indexed citations

Cui, Xiaojing, Liming Hou, Bowen Yan, et al.. (2025). Sexual dimorphism in the mouse bone marrow niche regulates hematopoietic engraftment via sex-specific Kdm5c/Cxcl12 signaling. Journal of Clinical Investigation. 135(5). 2 indexed citations

Ge, Guo, Peng Zhang, Ying Guo, et al.. (2023). Targeting lysine demethylase 6B ameliorates ASXL1 truncation–mediated myeloid malignancies in preclinical models. Journal of Clinical Investigation. 134(1). 3 indexed citations

Guo, Ying, Guo Ge, Ganqian Zhu, et al.. (2023). Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clipping. EMBO Reports. 24(10). e57032–e57032. 14 indexed citations

Yang, Feng‐Chun, et al.. (2018). Lycium barbarum polysaccharide prevents cisplatin-induced MLTC-1 cell apoptosis and autophagy via regulating endoplasmic reticulum stress pathway. SHILAP Revista de lepidopterología.

Shi, Hui, et al.. (2018). Alteration in the Cytokine Secretion of Bone Marrow Stromal Cells from Patients with Chronic Myelomonocytic Leukemia Contribute to Impaired Hematopoietic Supportive Activity. Stem Cells International. 2018. 1–9. 7 indexed citations

Zhou, Yuan, Lin Liu, Jinhuan Wang, et al.. (2017). TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2-Driven Myeloid Malignancy Progression. Stem Cell Reports. 10(1). 166–179. 35 indexed citations

Chen, Yun, Yihang Pan, Wanke Zhao, et al.. (2017). Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia. PubMed. 4(6). 48–48. 35 indexed citations

Man, Na, Xiao‐Jian Sun, Yurong Tan, et al.. (2016). Differential role of Id1 in MLL-AF9–driven leukemia based on cell of origin. Blood. 127(19). 2322–2326. 14 indexed citations

10.

Li, Yan, Wen Xing, Yongzheng He, et al.. (2014). Interleukin 8/KC enhances G-CSF induced hematopoietic stem/progenitor cell mobilization in Fancg deficient mice. PMC. 2 indexed citations

11.

Stevenson, David A., David G. Little, Linlea Armstrong, et al.. (2013). Approaches to Treating NF1 Tibial Pseudarthrosis. Journal of Pediatric Orthopaedics. 33(3). 269–275. 44 indexed citations

12.

He, Yongzheng, Paul Childress, Marta Alvarez, et al.. (2012). Nmp4/CIZ Suppresses the Parathyroid Hormone Anabolic Window by Restricting Mesenchymal Stem Cell and Osteoprogenitor Frequency. Stem Cells and Development. 22(3). 492–500. 16 indexed citations

13.

Wu, Xiaohua, Shi Chen, Yuan Jin, et al.. (2011). p85α Regulates Osteoblast Differentiation by Cross-talking with the MAPK Pathway. Journal of Biological Chemistry. 286(15). 13512–13521. 19 indexed citations

14.

Chen, Shi, Sarah J. Burgin, Andrew S. McDaniel, et al.. (2010). Nf1−/− Schwann Cell-Conditioned Medium Modulates Mast Cell Degranulation by c-Kit-Mediated Hyperactivation of Phosphatidylinositol 3-Kinase. American Journal Of Pathology. 177(6). 3125–3132. 36 indexed citations

15.

Perry, Brandon C., Dan Zhou, Xiaohua Wu, et al.. (2008). Collection, Cryopreservation, and Characterization of Human Dental Pulp–Derived Mesenchymal Stem Cells for Banking and Clinical Use. Tissue Engineering Part C Methods. 14(2). 149–156. 222 indexed citations

16.

Goodman, Michael L., Shi Chen, Feng‐Chun Yang, & Rebecca J. Chan. (2008). Novel Method of Murine Embryonic Stem Cell-Derived Osteoclast Development. Stem Cells and Development. 18(1). 195–200. 4 indexed citations

17.

Yang, Feng‐Chun, Shi Chen, Hilary White, et al.. (2007). K-ras Is Critical for Modulating Multiple c-kit-Mediated Cellular Functions in Wild-Type and Nf1 +/− Mast Cells. The Journal of Immunology. 178(4). 2527–2534. 28 indexed citations

18.

Yang, Feng‐Chun, Chen Shi, Xiaohong Li, et al.. (2006). Nf1+/− mast cells induce neurofibroma like phenotypes through secreted TGF-β signaling. Human Molecular Genetics. 15(16). 2421–2437. 123 indexed citations

19.

Yang, Feng‐Chun, Shi Chen, Alexander G. Robling, et al.. (2006). Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1–haploinsufficient osteoclast functions. Journal of Clinical Investigation. 116(11). 2880–2891. 99 indexed citations

20.

Croker, Ben A., David M. Tarlinton, Leonie A. Cluse, et al.. (2002). The Rac2 Guanosine Triphosphatase Regulates B Lymphocyte Antigen Receptor Responses and Chemotaxis and Is Required for Establishment of B-1a and Marginal Zone B Lymphocytes. The Journal of Immunology. 168(7). 3376–3386. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact